Astellas Gears Up To Launch Caduet With Pfizer; Ramps Up Oncology Franchise With Seattle Genetics Agreement

Pfizer Japan and Tokyo-based Astellas announced Nov. 26 that that they will launch combo drug Caduet (amlodipine/atorvastatin) in Japan Dec. 2